Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Bayer Finerenone approved in Japan for chronic heart failure

Bayer application for regulatory approval of Aflibercept 8 mg accepted in China

Written By Ruchika Sharma26 Jan 2024 4:00 PM IST

Berlin: Bayer has announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) accepted the...

Siemens Healthineers, IISc unveil laboratory for AI in precision medicine

Written By Ruchika Sharma26 Jan 2024 1:00 PM IST

New Delhi: Siemens Healthineers and the Indian Institute of Science (IISc) has inaugurated the Siemens Healthineers-Computational Data Sciences...

Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 crore

Bristol Myers Squibb concludes acquisition of Mirati Therapeutics

Written By Ruchika Sharma26 Jan 2024 12:15 PM IST

The transaction is expected to be treated as a business combination and to be dilutive to Bristol Myers Squibb's non-GAAP earnings per share by...

Sanofi India appoints Haresh Vala as Company Secretary, Compliance Officer

Sanofi to acquire Inhibrx

Written By Ruchika Sharma26 Jan 2024 10:00 AM IST

Paris: Sanofi and Inhibrx, Inc., a publicly traded clinical-stage biopharmaceutical company, have entered into a definitive agreement under which...

Bayer names Nelson Ambrogio as new head of Radiology business at pharmaceuticals division

Written By Ruchika Sharma25 Jan 2024 5:40 PM IST

Berlin: Bayer has announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals Division, effective April 1, 2024....

USFDA to Review Peptide Compounding Ban, Advisory Panel Meet Set for July

Siemens Healthineers announces FDA clearance of syngo Virtual Cockpit Remote Scanning Technology

Written By Ruchika Sharma25 Jan 2024 3:30 PM IST

Malvern: Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual Cockpit, a private, secure...

AI Meets Pharma: Novo Nordisk Teams Up with OpenAI for Faster Drug Innovation

3 US cases of hypoglycemia linked to suspected fake Ozempic

Written By Ruchika Sharma25 Jan 2024 12:45 PM IST

Three people sought medical treatment for dangerously low blood sugar in the U.S. last year after taking suspected fake versions of Novo Nordisk's...

Exempt cancer, rare-disease drugs from tax in budget: Biocon Chief urges govt

Powered by innovative drugs, pharma industry can be worth USD 200 billion by 2030: Biocon Chief

Written By Ruchika Sharma25 Jan 2024 12:17 PM IST

Mazumdar-Shaw also sought that the government ought to decouple private sector investment and ensure that academic research institutes are funded out...

GSK arm Tesaro initiates litigation against AnaptysBio

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Written By Ruchika Sharma24 Jan 2024 4:11 PM IST

GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in...

Quadria Capital-Led Consortium Eyes Majority Stake in Samarth Lifesciences at Rs 4,500 Cr Valuation

Sandoz to buy eye drug Cimerli business from Coherus BioSciences for over Rs 1413 crore

Written By Ruchika Sharma24 Jan 2024 1:30 PM IST

Basel: Sandoz has signed an agreement to acquire the US biosimilar ranibizumab CIMERLI (ranibizumab-eqrn) from Coherus BioSciences, Inc. for an...

Revolutionising Pharma-MedTech: India allocates Rs 5000 crore to propel research, innovation

Written By Ruchika Sharma24 Jan 2024 12:30 PM IST

The Ministry of Finance envisions the PRIP scheme as a transformative programme designed to elevate the research and innovation landscape in the...

USFDA Approves Corcept Therapeutics Ovarian Cancer Drug Lifyorli

Lupin bags tentative USFDA approval for Rivaroxaban Tablets

Written By Ruchika Sharma24 Jan 2024 11:19 AM IST

This product will be manufactured at Lupin's Pithampur facility in India.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok